Many U.S. hospitals using predictive models are not evaluating their tools internally for accuracy, and fewer still are evaluating them for potential biases, according to a study published in the most ...

Antoni Ribas, MD, PhD: For certain cancers where we know it can only work in a specific situation that has a specific marker, having a companion diagnostic makes a lot of sense. You want to select ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

New University of Utah research reveals the potential of medication informatics and DNA drug-sensitivity testing to reduce overall healthcare resource use and costs in elderly patients treated with ...

The prostate cancer (PC) treatment paradigm has recently changed again with the approval of abiraterone acetate with luteinizing hormone-releasing hormone analog for treatment-naïve metastatic disease ...